Mohamed Gamal: Rethinking The Standard of Care for Deep Vein Thrombosis Management
Mohamed Gamal, Physiotherapist at Kasr Al Ainy – School of Medicine, Cairo University, posted on LinkedIn:
”Rethinking the standard of care for Deep Vein Thrombosis (DVT) management.
The shift from mandatory bed rest to early mobilization for acute DVT patients is clearer than ever, supported by major professional guidelines. This is a critical update for clinicians across the board.
Here is a quick breakdown of the latest recommendations:
The Consensus: Both the American College of Chest Physicians (ACCP) and the American Physical Therapy Association (APTA) promote early ambulation over initial bed rest for stable, adequately anticoagulated DVT patients.
The Strength of Evidence:
APTA: Provides a Strong Recommendation (High-Quality Evidence) for Physical Therapists to initiate mobilization for lower-extremity DVT once therapeutic anticoagulation levels are reached. They also recommend mobilization after IVC filter placement as a Best Practice point.
ACCP: Offers a Weak Recommendation (Low-Quality Evidence) for early ambulation, noting that mobilization should be deferred if a patient has severe pain and edema.
The evidence suggests that early mobilization does not increase the risk of Pulmonary Embolism (PE) or DVT progression compared to bed rest and can improve DVT- related symptoms like pain.
Keep the momentum going toward evidence-based, active recovery.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis
-
Jan 12, 2026, 01:45Khurram Nasir on Where The Cholesterol Guidelines Are Headed
-
Jan 12, 2026, 01:35Nirav Dhanesha Shares The Lab’s Latest Publication on Neutrophil CD14 and DVT Link
-
Jan 12, 2026, 01:30Exploring the Grey Zone of Subacute Coronary Artery Occlusion